Antiviral Agent | ImmuneMed

Antiviral Agent

Antiviral Agent
(New Drug Division)

  • Expansion of indications of hzVSF through various virus-infected cell experiments
  • Continued clinical efficacy checks and feedback of hzVSF for the treatment of influenza and acute viral diseases
  • phase II clinical trial for Hepatitis B
  • Phase I~III clinical trials for COVID-19
  • Nonclinical and clinical studies for the development of therapeutic agents for skin diseases
  • Partner management and licensing activities